(Q44700233)

5 December 2017

title

Isolation of fluoroquinolone-resistant Escherichia coli and Klebsiella pneumoniae from an infected Hickman catheter (English)

1 reference

5 December 2017

main subject

Klebsiella pneumoniae

0 references

1 reference

M López-Brea

1

1 reference

5 December 2017

T Alarcón

series ordinal

2

1 reference

5 December 2017

publication date

1 May 1990

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

5 December 2017

published in

1 reference

5 December 2017

volume

9

1 reference

5 December 2017

issue

5

1 reference

5 December 2017

page(s)

345-347

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01973741

5 December 2017

exact match

0 references

cites work

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

1 reference

https://api.crossref.org/works/10.1007%2FBF01973741

Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: proof provided by typing with a DNA probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01973741

Norfloxacin resistance in a clinical isolate of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01973741

Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01973741

Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01973741

Quinolone resistance in clinical isolates of Serratia marcescens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01973741

Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01973741

Mechanisms of resistance to quinolones and clinical perspectives

21 January 2018

1 reference

12 December 2020

The frequency of in-vitro resistance development to fluoroquinolones and the use of a murine pyelonephritis model to demonstrate selection of resistance in vivo

1 reference

12 December 2020

Development of resistance during antibiotic therapy

1 reference

12 December 2020

Ciprofloxacin therapy in cystic fibrosis

1 reference

12 December 2020

Ciprofloxacin therapy of respiratory tract infection with Pseudomonas aeruginosa

1 reference

12 December 2020

In-vitro selection of bacteria resistant to the 4-quinolone agents.

1 reference

12 December 2020

Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa

1 reference

12 December 2020

Resistance to ciprofloxacin.

1 reference

12 December 2020

Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.

1 reference

12 December 2020

Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.

1 reference

12 December 2020

Clinical resistance to long-term oral ciprofloxacin.

1 reference

12 December 2020

Emergence of ciprofloxacin-resistant Pseudomonas aeruginosa after combined therapy with ciprofloxacin and amikacin

1 reference

12 December 2020

Norfloxacin versus co-trimoxazole for treatment of urinary tract infections in adults: microbiological results of a coordinated multicentre study.

1 reference

12 December 2020

Oral ciprofloxacin in resistant urinary tract infections

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01973741

1 reference

5 December 2017

1 reference